N-Acetyltransferase from Chryseobacterium sp. strain 5-3B is an acetyl coenzyme A (acetyl-CoA)-dependent enzyme that catalyzes the enantioselective transfer of an acetyl group from acetyl-CoA to the amino group of L-2-phenylglycine to produce (2S)-2-acetylamino-2-phenylacetic acid. We purified the enzyme from strain 5-3B and deduced the N-terminal amino acid sequence. The gene, designated natA, was cloned with two other hypothetical protein genes; the three genes probably form a 2.5-kb operon. The deduced amino acid sequence of NatA showed high levels of identity to sequences of putative N-acetyltransferases of Chryseobacterium spp. but not to other known arylamine and arylalkylamine N-acetyltransferases. Phylogenetic analysis indicated that NatA forms a distinct lineage from known N-acetyltransferases. We heterologously expressed recombinant NatA (rNatA) in Escherichia coli and purified it. rNatA showed high activity for L-2-phenylglycine and its chloro-and hydroxyl-derivatives. The K m and V max values for L-2-phenylglycine were 0.145 ؎ 0.026 mM and 43.6 ؎ 2.39 mol · min ؊1 · mg protein ؊1 , respectively. The enzyme showed low activity for 5-aminosalicylic acid and 5-hydroxytryptamine, which are reported as good substrates of a known arylamine N-acetyltransferase and an arylalkylamine N-acetyltransferase. rNatA had a comparatively broad acyl donor specificity, transferring acyl groups to L-2-phenylglycine and producing the corresponding 2-acetylamino-2-phenylacetic acids (relative activity with acetyl donors acetyl-CoA, propanoyl-CoA, butanoyl-CoA, pentanoyl-CoA, and hexanoyl-CoA, 100:108:122:10:<1).
Optically active D-amino acids are widely used in the pharmaceutical industry as intermediates for the synthesis of semisynthetic antibiotics, pesticides, and biologically active peptides. Among them, the demand has been increasing for D-2-phenylglycine and its hydroxyl-derivative, D-4-hydroxy-2-phenylglycine, for the synthesis of drugs such as aspoxicillin and cefpiramide (1, 2). Various procedures for the bio-production of D-2-phenylglycines have been studied, such as production from DL-p-hydroxyphenylhydantoin by hydantoinase and carbamylase (3), from its keto analogue by D-amino acid aminotransferase (4), and from DL-2-phenylglycine using isoelectrically trapped penicillin G acylase (5) and bioconversion via the L-glutamate metabolic pathway (6). However, these procedures need to be improved to obtain large amounts and high purity of 2-phenylglycines (7). Also the organic synthesis of D-2-phenylglycines via hydrocyanation of Nbenzyloxycarbonyl aldimine and hydrolysis of the reaction product, the carbamic acid derivative, has been reported (8), but this precise synthesis using a bimetallic salt catalytic agent needs to be scaled up in the manufacturing process.Arylamine N-acetyltransferase (NAT; EC 2.3.1.5) and arylalkylamine N-acetyltransferase (AANAT; EC 2.3.1.87) catalyze the transfer of an acetyl group from acetyl coenzyme A (acetyl-CoA) to the amino groups of hydrazine, arylamine drugs, carcinogens, and ar...